Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

T-Cell Abnormalities in Patients with Myelodysplastic Syndromes: Improved Immunological Functions in Patients Treated with Recombinant Erythropoietin.

Sara Prutchi-Sagiv, MSc, Nataliya Golishevski, MD, Odelia Katz, MSc, Howard S. Oster, MD PhD, Elizabeth Naparstek, MD, Michael Hoffman, MD, Drorit Neumann, PhD, Moshe Mittelman, MD

Blood (2006) 108 (11): 2675.

https://doi.org/10.1182/blood.V108.11.2675.2675

Published: 2006

Journal Articles

Erythropoietin Treatment in Advanced Multiple Myeloma Is Associated with Improved Immunological Functions: Could It Be Beneficial in Early Disease?.

Sara Prutchi-Sagiv, MSc, Nataliya Golishevski, MD, Howard S. Oster, MD, PhD, Odelia Katz, MSc, Naparstek Elizabeth, MD, Amos Cohen, MD, Michael Hoffman, MD, Drorit Neumann, PhD, Moshe Mittelman, MD

Blood (2006) 108 (11): 3499.

https://doi.org/10.1182/blood.V108.11.3499.3499

Published: 2006

Journal Articles

Improved Glycemic Control in Diabetic Patients Treated with Recombinant Human Erythropoietin.

Odelia Katz, MSc, Nataliya Golishevski, MD, Howard S. Oster, MD, PhD, Lilach Lifshitz, BSc, Sari Prutchi-Sagiv, MSc, Michael Hoffman, MD, Moshe Mittelman, MD, Drorit Neumann, PhD

Blood (2006) 108 (11): 4228.

https://doi.org/10.1182/blood.V108.11.4228.4228

Published: 2006

Journal Articles

Recombinant Human Erythropoietin (rHuEpo) as an Anti-Myeloma Immunomodulatory Agent.

Sari Prutci-Sagiv, MsC, Odelia Katz, MsC, Lidor Yeyni, BsC, Alon Skaat, MD, Eran Barzilay, MD, Drorit Neumann, PhD, Moshe Mittelman, MD

Blood (2004) 104 (11): 4887.

https://doi.org/10.1182/blood.V104.11.4887.4887

Published: 2004

Journal Articles

Erythropoietin Augments Antibody Response to DNP in Immunized Mice.

Lidor Yeyni, Odelia Katz, MsC, Sari Prutchi-Sagiv, MsC, Alon Skaat, MD, Eran Barzilay, MD, Moshe Mittelman, MD, Drorit Neumann, PhD

Blood (2004) 104 (11): 4232.

https://doi.org/10.1182/blood.V104.11.4232.4232

Published: 2004

NARROW

T-Cell Abnormalities in Patients with Myelodysplastic Syndromes: Improved Immunological Functions in Patients Treated with Recombinant Erythropoietin.

Erythropoietin Treatment in Advanced Multiple Myeloma Is Associated with Improved Immunological Functions: Could It Be Beneficial in Early Disease?.

Improved Glycemic Control in Diabetic Patients Treated with Recombinant Human Erythropoietin.

Recombinant Human Erythropoietin (rHuEpo) as an Anti-Myeloma Immunomodulatory Agent.

Erythropoietin Augments Antibody Response to DNP in Immunized Mice.

Email alerts

ASH Publications

American Society of Hematology

T-Cell Abnormalities in Patients with Myelodysplastic Syndromes: Improved Immunological Functions in Patients Treated with Recombinant Erythropoietin.

Erythropoietin Treatment in Advanced Multiple Myeloma Is Associated with Improved Immunological Functions: Could It Be Beneficial in Early Disease?.

Improved Glycemic Control in Diabetic Patients Treated with Recombinant Human Erythropoietin.

Recombinant Human Erythropoietin (rHuEpo) as an Anti-Myeloma Immunomodulatory Agent.

Erythropoietin Augments Antibody Response to DNP in Immunized Mice.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only